111
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

A new perspective on metals and other contaminants in fluoridation chemicals

References

  • Mortvedt JJ. Heavy metal contaminants in inorganic and organic fertilizers. Fertil Res. 1996;43:55–61.
  • Mortvedt JJ, Beaton JD. Heavy metal and radionuclide contaminants in phosphate fertilizers. In: Tiessen H, editor. Phosphorus in the global environment. New York: John Wiley and Sons Ltd.; 1995. p. 93–106.
  • Dissanayake CB, Chandrajith R. Phosphate mineral fertilizers, trace metals and human health. J Natl Sci Found Sri Lanka. 2009;37:153–65.
  • Mortvedt JJ, Giordano PM. Crop uptake of heavy-metal contaminants in fertilizers. In: Drucker H, Wildung RE, editors. Biological implications of heavy metals in the environment. Conf.-750929, Tennessee: ERDA; 1977. p. 402–16.
  • National Sanitation Foundation International. NSF Fact Sheet on Fluoridation Chemicals. Available from: www.nsf.org/business/water_distribution/pdf/NSF_Fact_Sheet.pdf (accessed 2012 June).
  • National Sanitation Foundation International. NSF Fact Sheet on Fluoridation Chemicals. Available from: www.nsf.org/newsroom_pdf/NSF_Fact_Sheet_on_Fluoridation.pdf (accessed 2013 February).
  • US Environmental Protection Agency. Determination of metals and trace elements in water and wastes by inductively coupled plasma-atomic emission spectrometry. Revision 4.4 EMMC Version, Cincinnati, OH: Environmental Monitoring Systems Laboratory, Office of Research and Development; 1994.
  • American Water Works Association. AWWA standard for fluorosilicic acid, ANSI/AWWA B703-11; 2011.
  • Reeves TG. Water Fluoridation. A Manual for Engineers and Technicians. Atlanta, US Department of Health & Human Services, Public Health Service, CDC, 1986.
  • American Water Works Association. Fluoride overfeed can have serious consequences. Opflow; 1993 ;19:5.
  • Carton R. Middletown Maryland latest city to receive toxic spill of fluoride in their drinking water. Townsend Letter for Doctors, October, 1994.
  • Washington R. Norfolk could teach Wakefield about posting water alerts. Boston Herald, 9 August 2000.
  • Foskett SH. Marlboro water flooded with fluoride. Worcester Telegram and Gazette, 25 October 2003.
  • Detroit Now-WXYZ-TV. Spilled acid concerns residents in Macomb County, 29 July 2002.
  • Russell K. Fluoride suspected as 23 in Dublin grow ill. Contra Costa Times, 5 June 2002.
  • The Oregonian. Partially treated sewage enters Coos Bay waters. 3 October 2000.
  • Hardin J. Water plant loses fluoride. Post and Courier, 4 August 2000.
  • Griner D. Spill call delayed 2 hours. The Journal Gazette, 22 February 2001.
  • Donovan P. Update: three people treated for injuries following chemical leak. St. Louis, MO: KSDK; 2009.
  • Rizzo R. Hazmat teams rush to fluoride spill in Parleys Creek. The Salt Lake Tribune, 31 August 2007.
  • WQAD News. Hazmat crews respond to chemical spill at Rock Island water treatment plant. 24 March 2011.
  • National Response Center. Incident Summary Reports 723353; 709565; 632081; 627070; 594739; 590129; 571290; 562139; 552909; 549345; 537343 and 525003. Available from: www.nrc.uscg.mil/pls/apex/f?p = 109:1; 2000–2004.
  • Gessner BD, Beller M, Middaugh JP, Whitford GM. Acute fluoride poisoning from a public water system. N Engl J Med. 1994;330:95–9.
  • Petersen LR, Denis D, Brown D, Hadler JL, Helgerson SD. Community health effects of a municipal water supply hyperfluoridation accident. Am J Public Health. 1988;78:711–3.
  • Sidhu KS, Kimmer RO. Fluoride overfeed at a well site near an elementary school in Michigan. J Environ Health. 2002;65:16–21.
  • Penman AD, Brackin BT, Embrey R. Outbreak of acute fluoride poisoning caused by a fluoride overfeed, Mississippi, 1993. Public Health Rep. 1997;112:403–9.
  • Waterwatch of Utah. Elective water additive. H2SiF6-Na2SiF6-NaF. Risks and Liabilities. Homeland Security and Source Water Protection. Case Study, Fluoride Spill Mt. Dell Reservoir-Parley’s Canyon. 31 August 2007.
  • Doull J. Factors influencing toxicology. In: Casarett LJ, Doull J, editors. Toxicology. The basic science of poisons. New York: Macmillan Publishing Co.; 1975. p. 133–47.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Interaction profile for arsenic, cadmium, chromium and lead. Atlanta, GA: U. S. Department of Health and Human Services, Public Health Service; 2004.
  • Stokinger HE, Ashenburg NJ, DeVoldre J, Scott JK, Smith FA. The enhancing effect of the inhalation of hydrogen fluoride vapor on beryllium sulfate poisoning in animals. University of Rochester Atomic Energy Project, Contract W-7401-eng-49, 4 April 1949.
  • Eisenbud M. (Brush Beryllium Company-Luckey Experience). Memorandum to W. B. Harris regarding acute beryllium toxicity. 27 February 1961. (Germantown DOE History Archive.)
  • Varner JA, Jensen KF, Horvath W, Isaacson RL. Chronic administration of aluminum-fluoride or sodium-fluoride to rats in drinking water: alterations in neuronal and cerebrovascular integrity. Brain Res. 1998;784:284–98.
  • Sternweis PC, Gilman AG. Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc Natl Acad Sci USA. 1982;79:4888–91.
  • Kirk KL. Biochemistry of inorganic fluoride. In: Biochemistry of the elemental halogens and inorganic halides. New York: Plenum Press; 1991. p. 19–68.
  • Isaacson RL, Varner JA, Jensen KF. Toxin-induced blood vessel inclusions caused by the chronic administration of aluminum and sodium fluoride and their implications for dementia. Neuroprotective Agents. Ann N Y Acad Sci. 1997;825:152–66.
  • Brown RA, Cornwell DA, MacPhee MJ. Trace contaminants in water treatment chemicals: sources and fate. J AWWA. 2004;96:111–25.
  • American Conference of Governmental Industrial Hygienists. Hydrogen fluoride. Cincinnati, OH: ACGIH; 2005.
  • Kharasch ED. Sevoflurane: the challenges of safe formulation. APSF Newsl. 2007;48:55.
  • O’Neill B, Hafiz MA, DeBeer DA. Corrosion of Penlon sevoflurane vaporizers. Anesthesia. 2007;62:421.
  • Saltarelli M. Abbott addresses sevoflurane formulation. APSF Newsl. 2007;21:86.
  • Kharasch ED, Subbarao GN, Cromack KR, Stephens DA, Saltarelli MD. Sevoflurane formulation water content influences degradation by Lewis Acids in vaporizers. Anesth Analg. 2009;108:1796–802.
  • Raloff J. Drugged waters. Does it matter that pharmaceuticals are turning up in water supplies? Sci News. 1998;153:187–9.
  • Fick J, Soderstrom H, Lindberg RH, Phan C, Tysklind M, Larsson DGJ. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem. 2009;28:2522–7.
  • Hodge HC, Smith FA. Biological properties of inorganic fluorides. In: Simons JH, editor. Fluorine chemistry. New York: Academic Press; 1965. p. 41.
  • Gosselin RE, Hodge HC, Smith RP, Gleason MN. Ingredients index. In: Clinical toxicology of commercial products. Acute poisoning, 4th edn. Baltimore: Williams and Wilkins Co; 1976. p. 78.
  • Simonin P, Pierron A. Toxicite brute des derives fluores. C R Seances Soc Biol Ses Fil. 1937;124:133–4.
  • Utah State Legislature. Utah House Bill HB 72: Safe Drinking Water Disclosure Act. Available from: http://openstates.org/ut/bills/2013/HB72/documents/UTD00025488/; 2013
  • Weng C-N, Smith DB, Huntley GM. Treatment chemicals contribute to arsenic levels. Opflow. 2000;10:6–7.
  • US Environmental Protection Agency. Water: drinking water contaminants. Available from: water.epa.gov/drink/contaminants/index.cfm. EPA 816-F-09-0004 (accessed 2009 May).
  • US Environmental Protection Agency. 2012 Edition of the Drinking Water Standards and Health Advisories. Washington, DC: US Environmental Protection Agency, Office of Water, EPA 822-S-12-001, 2012. Available from: http://water.epa.gov/drink/standards/hascience.cfm http://water.epa.gov/action/advisories/drinking/upload/dwstandards2012.pdf
  • Hazan S (NSF International, Drinking Water Additives Certification Program). Letter to Ken Calvert, Chairman Subcommittee on Energy and the Environment, Committee on Science, US House of Representatives, 7 July 2000.
  • Casale R. Improving chemical handling procedures can help reduce associated treatment problems. J AWWA. 2001;93:95–106.
  • Hirzy JW, Carton RJ, Bonanni CD, Montanero CM, Nagle MF. Comparison of hydrofluorosilicic acid and pharmaceutical sodium fluoride as fluoridating agents-A cost-benefit analysis. Environ Sci Policy. 2013;29:81–6. [In Press Corrigendum. Environ Sci Policy. 2013, Available form: http://dx.doi.org/10/1016/j.envsci.2013·11·002].
  • Ferrandiz J, Abellan JJ, Gomez-Rubio V, Lopez-Quilez A, Sanmartin P, Abellan C, et al. Spatial analysis of the relationship between mortality from cardiovascular and cerebrovascular disease and drinking water hardness. Environ Health Perspect. 2004;112:1037–44.
  • Rubenowitz E, Molin I, Axelsson G, Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiology. 2000;11:416–21.
  • Bratby J. Coagulation and flocculation in water and wastewater treatment, 2nd edn. London: IWA Publishing; 2006.
  • Jekel MR, Heinzmann B. Residual aluminum in drinking-water treatment. JWSRT Aqua. 1989;38:281–8.
  • Driscoll CT, Letterman RD. Chemistry and fate of Al(III) in treated drinking water. J Environ Eng. 1988;114:21-37.
  • Rogers MAM, Simon DG. A preliminary study of dietary aluminium intake and risk of Alzheimer’s disease. Age Ageing. 1999;28:205–9.
  • Li L. The biochemistry and physiology of metallic fluoride: action, mechanism, and implications. Crit Rev Oral Biol Med. 2003;14:100–14.
  • Hunter Water. Fact Sheet. Drinking water: alum in water treatment. Available from: www.hunterwater.com.au/Resources/Documents/Fact-Sheets/Water-Quality/ALUM-IN-DRINKING-WATER_MAR2011.pdf
  • Hoogerwerf WA, Pasricha PJ. Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. New York: McGraw-Hill Medical Publishing Division; 2006. p. 967–81.
  • Friedman PA. Agents affecting mineral ion homeostasis and bone turnover. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. New York: McGraw-Hill Medical Publishing Division; 2006. p. 1647–78.
  • Pennington JA. Aluminium content of foods and diets. Food Addit Contam. 1987;5:161–232.
  • Kaehny WD, Hegg AP, Alfrey AC. Gastrointestinal absorption of aluminium from aluminium-containing antacids. New Engl J Med. 1977;296:1389–90.
  • Slanina P, Frech W, Ekstrom LG, Loof L, Slorach S, Cedergren A. Dietary citric acid enhances absorption of aluminium in antacids. Clin Chem. 1986;32:539–41.
  • Harris WR, Berthon G, Day JP, Exley C, Flaten TP, Forbes WF, et al. Speciation of aluminum in biological systems. J Toxicol Environ Health. 1996;48:543–68.
  • Varner JA, Horvath WJ, Huie CW, Naslund HR, Isaacson RL. Chronic aluminum fluoride administration: I. Behavioral observations. Behav Neural Biol. 1994;61:233–41.
  • Varner JA, Huie CW, Horvath WJ, Jensen KF, Isaacson RL. Chronic AlF3 administration: II. Selected histological observations. Neurosci Res Commun. 1993;13:99–104.
  • Bigay J, Deterre P, Pfister C, Chabre M. Fluoroaluminates activate transducin-GDP by mimicking the gamma-phosphate of GTP in its binding site. FEBS Lett. 1985;191:181–5.
  • Bigay J, Deterre P, Pfister C, Chabre M. Fluoride complexes of aluminium or beryllium act on G-proteins as reversibly bound analogues of the gamma phosphate of GTP. EMBO J. 1987;6:2907–13.
  • Chabre M. Aluminofluoride and beryllofluoride complexes: new phosphate analogs in enzymology. Trends Biochem Sci. 1990;15:6–10.
  • Li L, Fleming N. Aluminum fluoride inhibits phospholipase D activation by a GTP-binding protein-independent mechanism. FEBS Lett. 1999;458:419–23.
  • Parker KL, Schimmer BP. Pituitary hormones and their hypothalamic releasing factors. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. New York: McGraw-Hill Medical Publishing Division; 2006. p. 1489–510.
  • Farwell AP, Braverman LE. Thyroid and antithyroid drugs. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. New York: McGraw-Hill Medical Publishing Division; 2006. p. 1511–40.
  • Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. New York: McGraw-Hill Medical Publishing Division; 2006. p. 1587–612.
  • Westfall TC, Westfall DP. Neurotransmission. The autonomic and somatic motor nervous systems. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. New York: McGraw-Hill Medical Publishing Division; 2006. p. 137–81.
  • Strunecka A, Strunecky O, Patocka J. Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. Physiol Res. 2002;51:557–64.
  • Neri LC, Hewitt D. Aluminium, Alzheimer’s disease, and drinking water. Lancet. 1991;338:390.
  • Forbes WF, McAiney CA. Aluminium and dementia. Lancet. 1992;340:668–9.
  • Jacqmin H, Commenges D, Letenneur L, Barberger-Gateau P, Dartigues JF. Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol. 1994;139:48–57.
  • McLachlan DRC, Bergeron C, Smith JE, Boomer D, Rifat SL. Risk for neuropathologically confirmed Alzheimer’s disease and residual aluminium in municipal drinking water employing weighted residential histories. Neurology. 1996;46:401–5.
  • Taylor GA, Ferrier IN, McLoughlin IJ, Fairbairn AF, McKeith IG, Lett D, et al. Gastrointestinal absorption of aluminium in Alzheimer’s disease: response to aluminium citrate. Age Ageing. 1992;21:81–90.
  • Moore PB, Edwardson JA, Ferrier IN, Taylor GA, Lett D, Tyrer SP, et al. Gastrointestinal absorption of aluminium is increased in Down’s syndrome. Biol Psychiatry. 1997;41:488–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.